...
首页> 外文期刊>Infection and immunity >Inhibition of Leishmania donovani promastigote internalization into murine macrophages by chemically defined parasite glycoconjugate ligands.
【24h】

Inhibition of Leishmania donovani promastigote internalization into murine macrophages by chemically defined parasite glycoconjugate ligands.

机译:化学定义的寄生虫糖缀合物配体抑制多形利什曼原虫前鞭毛体内在化进入鼠巨噬细胞。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Leishmania donovani, the agent of human visceral leishmaniasis, is an intracellular parasite that must be recognized and internalized by host macrophages to complete its biological cycle. In a search for possible ligands for macrophage surface receptors, glycoconjugates were obtained from Leishmania promastigotes by aqueous, phenol-aqueous, and alkaline extraction. A fucose-mannose glycoproteic ligand, a lipopeptidephosphoglycan, and a phosphate mannogalactan ligand were purified from promastigotes and analyzed for their chemical contents, with special attention to their glycidic moieties. Sugars that were identified as components of these glycoconjugates were tested for their capacity to inhibit promastigote internalization by BALB/c peritoneal macrophages in vitro. Neutral hexoses showed little inhibitory activity; fucose, charged monosaccharides, and a mannose polymer showed the highest activity. Two of the glycoconjugates (fucose-mannose glycoproteic ligand and phosphate mannogalactan ligand) purified from promastigotes were potent inhibitors of internalization, 75% inhibition being obtained at concentrations of 6 to 10 micrograms/ml. The simultaneous presence of both ligands in low concentrations yielded an increase in inhibitory activity above that found for each ligand alone, indicating that promastigotes may use at least two receptor sites for penetration into macrophages. These ligands are specific inhibitors of L. donovani promastigote phagocytosis, since 10 micrograms of each ligand per ml interfered neither with internalization of yeast cells nor with phagocytosis of Leishmania adleri promastigotes.
机译:人内脏利什曼病的病原体利什曼原虫是一种细胞内寄生虫,必须被宿主巨噬细胞识别并内在化才能完成其生物学循环。为了寻找巨噬细胞表面受体的可能配体,通过水,苯酚-水和碱萃取从利什曼原虫前鞭毛体获得糖缀合物。从前鞭毛体中纯化了岩藻糖-甘露糖糖蛋白配体,脂肽磷酸聚糖和磷酸甘露半乳聚糖配体,并对其化学成分进行了分析,尤其要注意其糖苷部分。测试了被鉴定为这些糖结合物成分的糖在体外通过BALB / c腹膜巨噬细胞抑制前鞭毛体内部化的能力。中性己糖几乎没有抑制活性。岩藻糖,带电单糖和甘露糖聚合物显示出最高的活性。从前鞭毛体纯化的两种糖缀合物(岩藻糖-甘露糖糖蛋白配体和磷酸甘露半乳聚糖配体)是有效的内化抑制剂,在6至10微克/毫升的浓度下可获得75%的抑制作用。两种配体同时以低浓度存在,其抑制活性比单独使用每种配体所发现的抑制活性增加,这表明前鞭毛体可能利用至少​​两个受体位点渗透进入巨噬细胞。这些配体是多诺氏乳杆菌前体吞噬作用的特异性抑制剂,因为每毫升10微克的每个配体既不影响酵母细胞的内化作用,也不干扰利什曼原虫的前体吞噬作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号